Substances for which PSUR work sharing is requested
Here you will find requests addressed to the manufacturers of generics regarding submission of PSURs within the PSUR work sharing project for procedures for which Germany is responsible (DE = P-RMS).
Search results 1 to 20 from a total of 28 (2 pages).
| Date | Title | Link |
|---|---|---|
| 2012.05.10 |
PSUR Worksharing Project: Assessment of the active substance Eprosarten and the combination of the active substances Eprosartan and Hydrochlorothiaside A PSUR on eprosartan and the combination of the active substances eprosartan and hydrochlorothiazide is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM has taken the role of the P-RMS. Companies interested in participating in the PSUR Worksharing Project for the a.m. substance respectively a.m. combination of active substances are requested to submit a PSUR. |
to article |
| 2012.05.10 |
PSUR Worksharing Project: Evaluation of Mefloquin A PSUR on mefloquin is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the a.m. substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2012.04.05 |
PSUR Worksharing Project: Evaluation of Triptorelin A PSUR on triptorelin is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2012.03.05 |
PSUR Worksharing Project: Evaluation of 17a-estradiol A PSUR on 17a-estradiol is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2012.03.05 |
PSUR Worksharing Project: Evaluation of Gadobutrol A PSUR on gadobutrol is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2012.02.06 |
PSUR Worksharing Project: Evaluation of Ramipril A PSUR on ramipril is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.12.12 |
PSUR Worksharing Project: Assessment of the combination of the active substances Chlormadinone acetate and Ethinylestradiol The combination of the active substances chlormadinone acetate and ethinylestradiol will be assessed as part of the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM has taken the role of the P-RMS. Companies interested in participating in the PSUR Worksharing Project for the a.m. combination of active substances are requested to submit a PSUR. |
to article |
| 2011.11.07 |
PSUR Worksharing Project: Evaluation of Olmesartan A PSUR on olmesartan is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.11.07 |
PSUR Worksharing Project: Assessment of the combination of the active substances Olmesartan/Hydrochlorothiazid The combination of the active substances olmesartan and hydrochlorothazid will be assessed as part of the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM has taken the role of the P-RMS. Companies interested in participating in the PSUR Worksharing Project for the a.m. combination of active substances are requested to submit a PSUR. |
to article |
| 2011.11.07 |
PSUR Worksharing Project: Evaluation of Atorvastatin A PSUR on atorvastatin is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.10.07 |
PSUR Worksharing Project: Evaluation of Trapidil A PSUR on trapidil is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.09.06 |
PSUR Worksharing Project: Evaluation of Ramipril combined with Piretanide A PSUR on ramipril combined with piretanide is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned combination of substances who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.08.08 |
PSUR Worksharing Project: Evaluation of Timolol (for ophtalmic use) A PSUR on timolol (for ophtalmic use) is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.08.08 |
PSUR Worksharing Project: Evaluation of Levocetirizine A PSUR on levocetirizine is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.06.10 |
PSUR Worksharing Project: Evaluation of Nadifloxacin A PSUR on nadifloxacin is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.06.10 |
PSUR Worksharing Project: Evaluation of Moxifloxacin A PSUR on moxifloxacin is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.06.10 |
PSUR Worksharing Project: Evaluation of Remifentanil A PSUR on remifentanil is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.06.10 |
PSUR Worksharing Project: Evaluation of Goserelin A PSUR on goserelin is up for evaluation in the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM will be the P-RMS. Companies concerned with the above-mentioned substance who wish to take part in the PSUR Worksharing Project, are requested to submit a PSUR. |
to article |
| 2011.04.12 |
PSUR Worksharing Project: Assessment of the combination of the active substances ezetimibe/simvastatin The combination of the active substances ezetimibe/simvastatin will be assessed as part of the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM has taken the role of the P-RMS. Companies interested in participating in the PSUR Worksharing Project for the a.m. combination of active substances are requested to submit a PSUR. |
to article |
| 2010.11.10 |
PSUR Worksharing Project: Assessment of the combination of the active substances atenolol/nifedipine The combination of the active substances atenolol/nifedipine will be assessed as part of the PSUR Worksharing Project of the Heads of Medicines Agencies (HMA). The BfArM has taken the role of the P-RMS. Companies interested in participating in the PSUR Worksharing Project for the a.m. substance combination are requested to submit a PSUR. |
to article |